Trailing-twelve-month (TTM) revenue is $145.68 Billion with a year-over-year growth of +18.33%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $32,649,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q4 FY2025Period ended 2025-12-31 | $32,515,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-19 |
| Q1 FY2026Period ended 2026-03-31 | $39,648,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-29 |
| Q2 FY2026Period ended 2026-06-30 | $40,867,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-29 |
| TTM revenue | $145,679,000,000 |
Current P/S: $49,214,788,000 market capitalization ÷ $145,679,000,000 TTM revenue = 0.34x.
Market capitalization source: FMP quote. Quote observed 2026-09-11T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $40.87B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-12T00:15:35.677Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-10.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| CenterWell Segment | N/A | N/A | $17.3B | $18.4B | $19.9B | $22.5B |
| Group And Specialty | $7.3B | $6.9B | N/A |
$145.68B
$145.68 Billion
+18.33%
vs. $123.11B a year ago (TTM)
+12.61%
5 Year compound annual growth rate
1 Year
+18.33%
3 Year
+13.84%
5 Year
+12.61%
10 Year
+10.33%
15 Year
+9.94%
20 Year
+11.15%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $129.66B | +$11.85B | +10.06% |
| 2024 | $117.81B | +$11.37B | +10.68% |
| 2023 | $106.44B | +$13.52B | +14.55% |
| 2022 | $92.92B | +$9.27B | +11.09% |
| 2021 | $83.65B | +$6.46B | +8.36% |
| 2020 |
TTM Growth
+18.33%
3-Year CAGR
+13.84%
5-Year CAGR
+12.61%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-12T00:15:35.677Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-10.
| N/A |
| N/A |
| N/A |
| Healthcare Services | $28.4B | $31.2B | N/A | N/A | N/A | N/A |
|---|
| Insurance Segment | N/A | N/A | $88.8B | $102.9B | $113.8B | $124.6B |
|---|
| Retail Segment | $67.3B | $74.0B | N/A | N/A | N/A | N/A |
|---|
| $77.19B |
| +$12.26B |
| +18.88% |
| 2019 | $64.93B | +$7.99B | +14.03% |
| 2018 | $56.94B | +$3.14B | +5.84% |
| 2017 | $53.80B | ($605.00M) | (1.11%) |
| 2016 | $54.41B | +$116.00M | +0.21% |
